Effect of subacute methyl parathion administration on the pharmacokinetics and pharmacodynamics of nifedipine in rats

Environmental Toxicology and Pharmacology

Volumn 24, Issue 1, 2007, Pages 1-4

  Gelal, Ayse ^a   Eminoglu, Ozlem ^a   Kaplan, Y Cem ^a   Kalkan, Sule ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

CYP450; Methyl parathion; Nifedipine; Organophosphate pesticides; Rats

Indexed keywords

NIFEDIPINE; PARATHION METHYL; TAP WATER;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CANNULATION; CAROTID ARTERY; CHEMICAL INTERACTION; CONTROLLED STUDY; DILUTION; DRUG ELIMINATION; DRUG METABOLISM; DUODENUM; FEEDING; HEART RATE; INHIBITION KINETICS; JUGULAR VEIN; LD 50; MALE; MEAN ARTERIAL PRESSURE; METABOLIC INHIBITION; NONHUMAN; PRIORITY JOURNAL; RAT;

RATTUS;

EID: 34247096641     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2006.11.010     Document Type: Article

References (17)

1. Bain L.J., and LeBlanc G.A. Interaction of structurally diverse pesticides with the human MDR1 gene product P-glycoprotein. Toxicol. Appl. Pharmacol. 141 (1996) 288-298
2. Benet L.Z., Izumi T., Zhang Y., Silverman J.A., and Wacher V.J. Intestinal MDR transport prote and P-450 enzymes as barriers to oral drug delivery. J. Control. Release 62 1-2 (1999) 25-31
3. Budavari S., Maryadele O.N., Smith A., and Heckelman P.E. The Merck Index, An Encyclopedia of Chemicals, and Biologicals. 11th ed. (1989), Merck&Co., Inc. Rahway, New Jersey
4. Butler A.M., and Murray M. Inhibition and inactivation of constitutive cytochromes P450 in rat liver by parathion. Mol. Pharmacol. 43 (1993) 902-908
5. Butler A.M., and Murray M. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation. J. Pharmacol. Exp. Ther. 280 (1997) 966-973
6. Dankers J., van den Elshout J., Ahr G., Brendel E., and van der Heiden C. Determination of nifedipine in human plasma by flow-injection tandem mass spectrometry. J. Chromatogr. B Biomed. Sci. Appl. 710 (1998) 115-120
7. Dresser G.K., Spence J.D., and Bailey D.G. Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. Clin. Pharmacokinet. 38 (2000) 41-57
8. Eliot L., and Jamali F.A. Pharmacokinetics and pharmacodynamics of nifedipine in untreated and atorvastatin-treated hyperlipidemic rats. J. Pharmacol. Exp. Ther. 291 (1999) 188-193
9. Gelal A., Gumustekin M., Kalkan S., Guven H., and Eminoglu O. Effects of subchronic parathion exposure on cyclosporine pharmacokinetics in rats. J. Toxicol. Environ. Health Part A 62 (2001) 289-294
10. Gupta P.K. Pesticide exposure-Indian scene. Toxicology 198 (2004) 83-90
11. Hunter A., and Neal R.A. Inhibition of hepatic mixed-function oxidase activity in vitro and in vivo by various thiono-sulfur-containing compounds. Biochem. Pharmacol. 24 (1975) 2199-2205
12. Iwao T., Inoue K., Hayashi Y., Yuasa H., and Watanabe J. Metabolic extraction of nifedipine during absorption from the rat small intestine. Drug Metab. Pharmacokinet. 17 (2002) 546-553
13. Kaur S., and Dhanju C.K. Enzymatic changes induced by some organophosphorus pesticides in female rats. Indian J. Exp. Biol. 42 (2004) 1017-1019
14. Morelli M., and Nakatsugawa T. Inactivation in vitro of microsomal oxidases during parathion metabolism. Biochem. Pharmacol. 27 (1978) 293-299
15. Murray M., and Reidy G.F. Selectivity in the inhibition of mammalian cytochromes P-450 by chemical agents. Pharmacol. Rev. 42 (1990) 85-101
16. Tuncok, Y., Guven, H., Gelal, A., Apaydin, S., Gidener, S., Fowler, J. (1995). Poisonings reported to the DPIC in Izmir, Turkey 1994. Toxicol. Lett. 78 (suppl).
17. Vodela J.K., and Dalvi R.R. Comparative toxicological studies of chlorpyrifos in rats and chicken. Vet. Hum. Toxicol. 37 (1995) 1-3